Drug General Information (ID: DDIMK5I3FD)
Drug Name			Aldesleukin		Drug Info		Bendroflumethiazide		Drug Info
Drug Type		Interferons				Small molecule
Therapeutic Class		Antineoplastics				Antihypertensive Agents

Mechanism of Aldesleukin-Bendroflumethiazide Interaction (Severity Level: Moderate)
Additive hypotensive effects Click to Show/Hide Mechanism Graph
Drug Name		Aldesleukin				Bendroflumethiazide
Mechanism 1		Antihypertensive agent				Antihypertensive agent
Key Mechanism Factor 1
		Factor Name		Hypotensive effects
		Factor Description		Hypotension is a blood pressure reading below the prescribed limit (90/60 mmHg). Symptoms of hypotension may include: blurred or faded vision , dizziness or light-headedness, fainting , fatigue , difficulty concentrating, nausea.
Mechanism Description		Additive hypotensive effects by the combination of Aldesleukin and Bendroflumethiazide
Mechanism 2		Hypotensive effects				Antihypertensive agent
Key Mechanism Factor 2
		Factor Name		Hypotensive effects
		Factor Description		Hypotension is a blood pressure reading below the prescribed limit (90/60 mmHg). Symptoms of hypotension may include: blurred or faded vision , dizziness or light-headedness, fainting , fatigue , difficulty concentrating, nausea.
Mechanism Description		Additive hypotensive effects by the combination of Aldesleukin and Bendroflumethiazide

Recommended Action
Management		Blood pressure should be monitored during concomitant administration. Aldesleukin doses should be held if systolic blood pressure falls to less than 90 mmHg.

References
1	Product Information. Proleukin (aldesleukin). Chiron Therapeutics, Emeryville, CA.